Cite Filings / SPRO / 0001193125-25-280174

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Spero Therapeutics, Inc. Filed 2025-11-13 Acc 0001193125-25-280174

Documents 1

10-Q Quarterly Report , spro-20250930.htm

Around this filing

2026-05-13 10-Q Quarterly Report
2025-11-13 8-K Results of operations · Regulation FD disclosure
2025-11-13 10-Q Quarterly Report
2025-11-12 4 See Remarks sold 40,270 shares at $2.37 ($95,440)
2025-08-12 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading spro-20250930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…